ATE491709T1 - Pyrrolidinohydrochinazoline - Google Patents

Pyrrolidinohydrochinazoline

Info

Publication number
ATE491709T1
ATE491709T1 AT04708347T AT04708347T ATE491709T1 AT E491709 T1 ATE491709 T1 AT E491709T1 AT 04708347 T AT04708347 T AT 04708347T AT 04708347 T AT04708347 T AT 04708347T AT E491709 T1 ATE491709 T1 AT E491709T1
Authority
AT
Austria
Prior art keywords
sup
pyrrolidinohydroquinazolines
stereoisomers
compounds
groups
Prior art date
Application number
AT04708347T
Other languages
English (en)
Inventor
Ralf Anderskewitz
Horst Dollinger
Claudia Heine
Pascale Pouzet
Franz Birke
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE491709T1 publication Critical patent/ATE491709T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04708347T 2003-02-12 2004-02-05 Pyrrolidinohydrochinazoline ATE491709T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003007 2003-02-12
PCT/EP2004/001043 WO2004072074A1 (en) 2003-02-12 2004-02-05 Pyrrolidinohydrochinazolines

Publications (1)

Publication Number Publication Date
ATE491709T1 true ATE491709T1 (de) 2011-01-15

Family

ID=32864927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04708347T ATE491709T1 (de) 2003-02-12 2004-02-05 Pyrrolidinohydrochinazoline

Country Status (8)

Country Link
US (1) US7214703B2 (de)
EP (1) EP1594873B1 (de)
JP (1) JP4574555B2 (de)
AT (1) ATE491709T1 (de)
CA (1) CA2515730C (de)
DE (1) DE602004030536D1 (de)
ES (1) ES2355624T3 (de)
WO (1) WO2004072074A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040192738A1 (en) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
GB0426266D0 (en) 2004-11-30 2004-12-29 Unilever Plc Compounds and their uses
US7879470B2 (en) * 2007-11-15 2011-02-01 Hitachi Global Storage Technologies Netherlands B.V. Apparatus, system, and method for the selection of perpendicular media segregant materials
CN113943308B (zh) * 2021-12-09 2023-11-10 中国科学院新疆理化技术研究所 一种三环嘧啶类衍生物及用途
CN117327028B (zh) * 2023-09-25 2024-07-23 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 吩噻嗪类衍生物、药物组合物及其在治疗棘球蚴病中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613905B1 (en) * 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2319435A1 (en) * 1998-12-04 2000-06-15 Toray Industries, Inc. Triazolo derivatives and chemokine inhibitors containing the same as effective component
EP1257555B1 (de) * 2000-02-11 2003-12-03 AstraZeneca AB Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität

Also Published As

Publication number Publication date
EP1594873B1 (de) 2010-12-15
US20050027122A1 (en) 2005-02-03
WO2004072074A1 (en) 2004-08-26
EP1594873A1 (de) 2005-11-16
JP2006515002A (ja) 2006-05-18
JP4574555B2 (ja) 2010-11-04
US7214703B2 (en) 2007-05-08
DE602004030536D1 (de) 2011-01-27
ES2355624T3 (es) 2011-03-29
CA2515730A1 (en) 2004-08-26
CA2515730C (en) 2011-04-05
ES2355624T8 (es) 2011-05-11

Similar Documents

Publication Publication Date Title
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
SE0202463D0 (sv) Novel compounds
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
SE0201544D0 (sv) Novel compounds and thier use
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
SE0101932D0 (sv) Pharmaceutical combinations
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
NO20052182L (no) Nye forbindelser
SE0003476D0 (sv) Compounds
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DK1204659T3 (da) Serotonerge benzofuraner
ATE491709T1 (de) Pyrrolidinohydrochinazoline
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DK1244643T3 (da) Tryptaseinhibitorer
SE0102058D0 (sv) New Salts II
DK1244614T3 (da) Tryptase-inhibitorer
DE60216920D1 (en) Tryptase-inhibitoren
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1594873

Country of ref document: EP